Long-term Survival and Value of CAR T-Cell Therapy for Pediatric Patients with Relapsed or Refractory Leukemia; Assessment of Exposure to High-Performing Schools and Risk of Adolescent Substance Use
JAMA Pediatrics Editors' Summary3 Dec 2018

Long-term Survival and Value of CAR T-Cell Therapy for Pediatric Patients with Relapsed or Refractory Leukemia; Assessment of Exposure to High-Performing Schools and Risk of Adolescent Substance Use

JAMA Pediatrics Editors' Summary by Dimitri Christakis, MD, MPH, Editor in Chief, and Frederick Rivara, MD, MPH, Editor of JAMA Network Open, for the December 3, 2018 issue

Populärt inom Vetenskap

p3-dystopia
paranormalt-med-caroline-giertz
dumma-manniskor
allt-du-velat-veta
rss-vetenskapligt-talat
svd-nyhetsartiklar
kapitalet-en-podd-om-ekonomi
rss-vetenskapspodden
dumforklarat
rss-vetenskapsradion-2
sexet
rss-vetenskapsradion
medicinvetarna
rss-ufobortom-rimligt-tvivel
rss-i-hjarnan-pa-louise-epstein
det-morka-psyket
bildningspodden
halsorevolutionen
rss-spraket
vetenskapsradion